These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33115289)

  • 1. Retrospective Evaluation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Postoperative Estimated Glomerular Filtration Rates Following Robotic-Assisted Partial Nephrectomy.
    Haehn DA; Shumate AM; Bajalia EM; Thomas Ball C; Irizarry-Alvarado JM; Thiel DD
    J Endourol; 2021 Jun; 35(6):808-813. PubMed ID: 33115289
    [No Abstract]   [Full Text] [Related]  

  • 2. Statin Use and Association with Postoperative Estimated Glomerular Filtration Rates in Patients Undergoing Robot-Assisted Partial Nephrectomy.
    Haehn DA; Bajalia EM; Albo GAG; Ball CT; Thiel DD
    J Endourol; 2022 Feb; 36(2):197-202. PubMed ID: 34663077
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term beneficial effects of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy for patients with advanced immunoglobulin A nephropathy and impaired renal function.
    Moriyama T; Amamiya N; Ochi A; Tsuruta Y; Shimizu A; Kojima C; Itabashi M; Takei T; Uchida K; Nitta K
    Clin Exp Nephrol; 2011 Oct; 15(5):700-707. PubMed ID: 21625892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do Renin-Angiotensin Blockers Affect Renal Function and Cardiac Outcomes in Patients Undergoing Partial Nephrectomy?
    Nyame YA; Liang H; Arora HC; Gill BC; Caputo P; Ramirez D; Maurice MJ; Fareed K; Stein RJ; Haber GP; Stephenson AJ; Fergany A; Kaouk J
    J Urol; 2017 Mar; 197(3 Pt 1):566-573. PubMed ID: 27746281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults.
    Zou Z; Yuan HB; Yang B; Xu F; Chen XY; Liu GJ; Shi XY
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD009210. PubMed ID: 26816003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.
    Wang Z; Zhang D; Wang S; Jin Y; Huan J; Wu Y; Xia C; Li Z; Qi X; Zhang D; Han X; Zhu X; Qu Y; Wang Q
    Med Sci Monit; 2020 Sep; 26():e926651. PubMed ID: 32969367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of Renin-angiotensin System Blockage on Recurrence of Non-muscle-invasive Bladder Cancer].
    Bai YJ; Wang XM; Han P; Yang YB; Tang Y; Wei Q; Wang J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 49(4):635-639. PubMed ID: 30378319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
    Cheng J; Zhang W; Zhang X; Han F; Li X; He X; Li Q; Chen J
    JAMA Intern Med; 2014 May; 174(5):773-85. PubMed ID: 24687000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-Angiotensin-Aldosterone System Optimization for Acute Decompensated Heart Failure Patients (ROAD-HF): Rationale and Design.
    Dass B; Dimza M; Singhania G; Schwartz C; George J; Bhatt A; Radhakrishnan N; Bansari A; Bozorgmehri S; Mohandas R
    Am J Cardiovasc Drugs; 2020 Aug; 20(4):373-380. PubMed ID: 31797310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide.
    Mamdani M; Gomes T; Greaves S; Manji S; Juurlink DN; Tadrous M; Kennedy SH; Antoniou T
    JAMA Netw Open; 2019 Oct; 2(10):e1913304. PubMed ID: 31617924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on anemia in patients with normal or mildly low glomerular filtration rate.
    Ergün B; Aybal Kutlugün A; Ergün MÇ; Aktürk G; Beyan E
    Turk J Med Sci; 2021 Dec; 51(6):3047-3052. PubMed ID: 34519192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transperitoneal Robot-assisted Partial Nephrectomy with Minimum Follow-up of 5 Years: Oncological and Functional Outcomes from a Single Institution.
    Bertolo R; Garisto J; Dagenais J; Sagalovich D; Stein R; Fareed K; Gao T; Armanyous S; Fergany A; Lioudis M; Kaouk J
    Eur Urol Oncol; 2019 Mar; 2(2):207-213. PubMed ID: 31017098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EVALUATING THE PRESCRIPTION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR RECEPTOR BLOCKERS IN PATIENTS WITH DIABETES IN JORDAN.
    Mayyas F; Bataineh W; Jarab A
    Endocr Pract; 2017 Nov; 23(11):1289-1296. PubMed ID: 28816537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Incidence and Risk of Biochemical Recurrence Following Radical Radiotherapy for Prostate Cancer in Men on Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin Receptor Blockers (ARBs).
    Alashkham A; Paterson C; Windsor P; Struthers A; Rauchhaus P; Nabi G
    Clin Genitourin Cancer; 2016 Oct; 14(5):398-405. PubMed ID: 27053500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials.
    Tai C; Gan T; Zou L; Sun Y; Zhang Y; Chen W; Li J; Zhang J; Xu Y; Lu H; Xu D
    BMC Cardiovasc Disord; 2017 Oct; 17(1):257. PubMed ID: 28982370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension.
    Kuan YC; Huang KW; Yen DJ; Hu CJ; Lin CL; Kao CH
    Int J Cardiol; 2016 Oct; 220():462-6. PubMed ID: 27390970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Lim S; Choo EH; Choi IJ; Ihm SH; Kim HY; Ahn Y; Chang K; Jeong MH; Seung KB
    J Korean Med Sci; 2019 Nov; 34(45):e289. PubMed ID: 31760711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the 'Better Care Better Value' prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimental design.
    Baker A; Chen LC; Elliott RA; Godman B
    BMC Health Serv Res; 2015 Sep; 15():367. PubMed ID: 26359265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentoxifylline plus ACEIs/ARBs for proteinuria and kidney function in chronic kidney disease: a meta-analysis.
    Liu D; Wang LN; Li HX; Huang P; Qu LB; Chen FY
    J Int Med Res; 2017 Apr; 45(2):383-398. PubMed ID: 28415944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of first-line antihypertensive drug classes on the maintenance of estimated glomerular filtration rate (eGFR) in real world primary care.
    Gao Q; Tan NC; Lee ML; Hsu W; Choo J
    Sci Rep; 2023 Dec; 13(1):21225. PubMed ID: 38040765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.